Candidate Agreement definition

Candidate Agreement means the set of terms that students must agree to as part of their Examination registration;
Sample 1Sample 2Sample 3
Candidate Agreement means an agreement between the University and another research institute or university for the joint supervision of a Degree.
Sample 1Sample 2
Candidate Agreement means the mandatory set of terms that govern a Candidate’s conduct with respect to an Examination;
Sample 1

Examples of Candidate Agreement in a sentence

  • This Temporary Candidate Agreement (‘TCA’) comprises the framework terms and conditions upon which we are willing to provide our Services, which we confirm are at no charge to you, and upon which you shall perform Assignments (‘these Terms’), and consists of TCA - Part 1, which sets out our primary terms, and TCA - Part 2 which contains our standard main terms.

  • For the purposes of this Candidate Agreement, the candidate’s immediate family is defined as only the candidate’s parent, grandparent, sibling, spouse/domestic partner, or child.

  • To be considered complete, the Candidate Agreement section must be signed and dated by the candidate and their local CEO.

  • Doctoral Candidate Agreement: an agreement, obligatory to all EMJDs, signed between the Consortium and each doctoral candidate enrolled in the joint doctorate programme explicitly indicating any academic, research, financial and administrative modalities related to the doctoral candidates participation in the joint course and, if applicable, the award and usage of the fellowship.

  • In addition to any other rights and remedies provided by law or this Candidate Agreement, CFA Institute hereby expressly reserves all of its rights and remedies arising out of a breach of this Candidate Agreement and/or any infringement of any CFA Institute trade secret, copyright and/or trademarks.

  • You understand CFA Institute has the authority to void your exam result, and reject, suspend, or terminate your candidacy at any time for your failure to comply with the Candidate Agreement.

  • As a candidate in the CFA Program, you must abide by the CFA Program Candidate Agreement, all testing policies and rules, CFA Institute governing documents including the Bylaws, the Code of Ethics, Standards of Professional Conduct, and Rules of Procedure, as amended from time to time.

  • The laws of the Commonwealth of Virginia, USA govern this Candidate Agreement.

  • Scottish Natural Heritage and The British Geological Survey 2004 in 'Cairngorms: A Landscape Fashioned by Geology'.

  • The parties agree that certain matters in which the Executive will be involved during the Employment Period may necessitate the Executive's cooperation in the future.

Related to Candidate Agreement

  • Collaboration Agreement has the meaning set forth in the Recitals.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • CMPPA Agreement means the CMPPA Agreement between the SSA and CHHS.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Development Plan has the meaning set forth in Section 3.2.

  • Development Schedule shall have the meaning set forth in Section 1.1.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Development Agreement has the meaning set forth in the Recitals.

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Phase I Trial means a Clinical Trial, the principal purpose of which is preliminary determination of safety of an investigational product in healthy individuals or patients or that otherwise meets the requirements described in 21 C.F.R. §312.21(a), or similar Clinical Trial in a country other than the United States.

  • Collaborative agreement means a voluntary, written, or electronic arrangement between one

  • DMF means a drug master file and all equivalents, and related proprietary dossiers, in any country or jurisdiction in the Territory (including any active substance master file in the EMA) for API submitted or to be submitted by a Party to Regulatory Authorities.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Clinical Supply Agreement has the meaning set forth in Section 4.2.

  • Joint Development Agreement has the meaning provided in Section 5.3.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Pharmacovigilance Agreement has the meaning set forth in Section 5.1.

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Quality Agreement has the meaning set forth in Section 9.6.

  • Tri-Party Agreement shall have the meaning set forth in Section 6.4 hereof.

  • Mediation agreement means a written agreement between the parties to a mediation meeting.

  • Development Agreements means all development, utility or similar agreements included in the Permitted Encumbrances.

  • Pivotal Clinical Trial means a human clinical trial in any country that is prospectively designed to generate data intended to satisfy the requirements of 21 C.F.R. § 312.21(c) (as amended) in the U.S. or a similar clinical study prescribed by a Regulatory Authority from another country, from time to time, pursuant to Applicable Law.

  • Clinical Trial means any human clinical trial of a Product.